Natixis’s Aurinia Pharmaceuticals AUPH Stock Holding History

Natixis’s Portfolio AUPH Stock Details AUPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-5,500	Closed	-$49.4K	–	979
2024 Q4	$49.4K	Buy	+5,500	New	+$44.9K	﹤0.01%	884
2024 Q2	–	Sell	-50,717	Closed	-$254K	–	1003
2024 Q1	$254K	Sell	50,717 -27,897	-35%	-$189K	﹤0.01%	694
2023 Q4	$707K	Sell	78,614 -217,541	-73%	-$1.79M	0.01%	576
2023 Q3	$2.3M	Buy	296,155 +33,899	+13%	+$332K	0.02%	389
2023 Q2	$2.54M	Sell	262,256 -963,231	-79%	-$10M	0.02%	388
2023 Q1	$13.4M	Buy	1,225,487 +250,544	+26%	+$2.21M	0.12%	155
2022 Q4	$4.21M	Buy	974,943 +846,998	+662%	+$4.91M	0.02%	404
2022 Q3	$977K	Sell	127,945 -872,055	-87%	-$7.55M	﹤0.01%	768
2022 Q2	$9.91M	Hold	1,000,000	–	–	0.04%	291
2022 Q1	$12.4M	Buy	1,000,000 +500,000	+100%	+$7.73M	0.04%	367
2021 Q4	$11.4M	Buy	+500,000	New	+$11.8M	0.04%	355

Other funds holding AUPH

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Arrowstreet Capital

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return